Literature DB >> 765266

Partial characterization of an immunoenhancing factor from allogeneic human lymphocyte cell lines.

A S Rubin, A B Macdonald.   

Abstract

The mixing of two histoincompatible human lymphocyte cell lines generated the release of a soluble factor which was capable on non-specifically enhancing the in vitro immune response of normal mouse spleen cells against sheep erythrocytes. The mediator was secreted into the supernatant of the allogeneic cell cultures within 24 h of cultuvation. The human enhancing factor (HEF) must be added to assay cultures on day 2, of a 5-day culture period, for its activity to be manifest. HEF was resistant to DNase, RNase and heating at 56 degrees for 30 min, but was inactivated by exposure to protease or elevated temperature (80 degrees for 30 min). The molecular weight of HEF, purified by ammonium sulphate fractionation, followed by Sephadex gel filtration, DEAE-cellulose chromatography and SDS-polyacrylamide gel electrophoresis, was approximately 38,000 Daltons.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 765266      PMCID: PMC1444960     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Complement receptor in synchronized cultures of human hematopoietic cell lines.

Authors:  P Papenhausen; P Papageorgiou; K Hirschhorn
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  A human lymphoid cell line with receptors for both sheep red blood cells and complement.

Authors:  W West; R B Herberman
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

3.  Initiation of antibody production to sheep erythrocytes in vitro: replacement of the requirement for T-cells with a cell-free factor isolated from cultures of lymphoid cells.

Authors:  R M Gorczynski; R G Miller; R A Phillips
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

4.  Products of lymphoid cells in continuous culture.

Authors:  P R Glade; K Hirschhorn
Journal:  Am J Pathol       Date:  1970-09       Impact factor: 4.307

5.  T cell products activating stem cells: further studies on the origin and action of the factor(s).

Authors:  J Cerny; E B Waner; A S Rubin
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

6.  Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines.

Authors:  E M Shevach; R Herberman; M M Frank; I Green
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

7.  Specific heterologous enhancement of immune responses.

Authors:  A S Rubin; A H Coons
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

8.  Induction of immunity and tolerance in vitro by hapten protein conjugates. I. The relationship between the degree of hapten conjugation and the immunogenicity of dinitrophenylated polymerized flagellin.

Authors:  M Feldmann
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

9.  Cell interactions in the immune response in vitro. IV. Comparison of the effects of antigen-specific and allogeneic thymus-derived cell factors.

Authors:  M Feldmann; A Basten
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

10.  Specific heterologous enhancement of immune responses. VI. Partial purification of a nonspecific enhancing factor from supernates of allogeneically stimulated human lymphocyte cell lines.

Authors:  A S Rubin; A B MacDonald; A H Coons
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

View more
  1 in total

1.  Influence of proteolysis inhibitors and immunoadsorption technique on the composition of rabbit antigen-specific receptor preparations. Presence of Fc receptors.

Authors:  L Tucková; J Zikán; J Rejnek; J Kostka
Journal:  Folia Microbiol (Praha)       Date:  1983       Impact factor: 2.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.